Endogenous interleukin 6 production in multiple myeloma patients treated with chimeric monoclonal anti-IL6 antibodies indicates the existence of a positive feed-back loop.
J. Clin. Invest. 98:6 doi:10.1172/JCI118932
[Go to this article.]

Problems with a PDF?